Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →HDFC Life reported a mixed H1 FY24 with individual WRP growth of 10% and PAT of INR 792 crore (+15% YoY).
✓ Verified against BSE filing
HDFC Life reported a mixed H1 FY24 with individual WRP growth of 10% and PAT of INR 792 crore (+15% YoY). New business margin was 26.2% with VNB of INR 1,411 crore (+10% YoY). Growth was driven by strong protection (+46% retail protection) and bancassurance (+23% YoY), with HDFC Bank counter share rising to 62.2%. However, higher ticket (>INR 5 lakh) business declined, dragging overall APE growth to ~10%. Management expects mid-teens APE growth for FY24 and flattish margins, with H2 recovery in high-ticket segments. Key risks include sustained degrowth in high-ticket business and competitive pressure on non-par pricing.
HDFC Life ने H1 FY24 में मिला-जुला प्रदर्शन दिखाया। पहली बार प्रीमियम (नियमित भुगतान वाली पॉलिसी) में 10% बढ़ोतरी हुई। कंपनी का मुनाफा (PAT) 792 करोड़ रुपये रहा, जो पिछले साल से 15% ज्यादा है। नए कारोबार का मार्जिन 26.2% रहा और VNB (नए कारोबार से मूल्य) 1,411 करोड़ रुपये (+10%) हुआ। बीमा (खासकर रिटेल प्रोटेक्शन में 46% बढ़ोतरी) और बैंक के जरिए बिक्री (बैंकाश्योरेंस) में 23% वृद्धि से ग्रोथ मिली। HDFC Bank का हिस्सा 62.2% हो गया। लेकिन 5 लाख से ज्यादा की बड़ी पॉलिसियों की बिक्री घटी, जिससे कुल APE (सालाना प्रीमियम) सिर्फ 10% बढ़ा। कंपनी को FY24 में APE में मध्यम दो अंकों की ग्रोथ और मार्जिन स्थिर रहने की उम्मीद है। बड़ी पॉलिसियों में गिरावट और प्रतिस्पर्धी दबाव मुख्य जोखिम हैं।
0 delivered, 0 close, 1 missed.
View Promises →Sustained degrowth in high-ticket business
View Risks →Full transcript text is available on this route.
Read Transcript →Individual weighted received premium growth for H1 FY24, beating industry growth of 8%.
Retail protection new business premium grew 46% YoY in H1 FY24, driven by product launches.
Market share at HDFC Bank channel improved to 62.2% in H1 FY24 from ~56.5% in Q1.
Number of individual policies sold grew 10% YoY, beating industry growth.
Management expects full-year VNB margins to remain flattish versus FY23, around 26%.
Expect improved traction in >INR 5 lakh ticket size business in H2 due to product launches and customer adaptation.
Management expects full-year APE growth in mid-teens, implying a strong H2 recovery.
Management expects full-year new business margin to be similar to FY23 (26.2% in Q1), with VNB expansion led by APE growth rather than margin expansion.
Project Inspire tech transformation will spend INR 100 crore in FY24 (total outlay INR 250 crore over 3 years).
Management expects to achieve margin neutrality (similar to FY23) by end of FY24, with Q1 margin impacted by tax-related demand upfronting.
Business above INR 5 lakh ticket size declined ~20% in H1, and if recovery in H2 is slower than expected, overall APE growth may miss guidance.
Total cost ratio increased to 19.7% due to lower growth absorption; if growth does not pick up, margins could compress.
Some players offer higher IRRs, potentially pressuring HDFC Life's non-par margins if they need to match pricing.
A show cause notice for INR 942 crore was received; outcome could impact financials if adverse.
Management acknowledged that achieving 30% margins would require losing market share, implying a deliberate trade-off between margin expansion and market share growth.
Analyst questioned the path to 70% wallet share; management indicated it will be gradual and calibrated, with no specific timeline, suggesting execution risk.
Analyst raised concerns about competitive pressures and flat yield curve impacting non-par savings margins; management confirmed pricing discipline but noted potential lag in repricing.
Analyst questioned whether the bank's commission structure would change post-merger; management deflected, saying it's part of ongoing discussions, leaving uncertainty.
Management expects full-year APE growth in mid-teens, implying a strong H2 recovery.
Business above INR 5 lakh ticket size declined ~20% in H1, and if recovery in H2 is slower than expected, overall APE growth may miss guidance.
View Risks →